financetom
Business
financetom
/
Business
/
Update: Market Chatter: Paramount Global Asked by Activist Investor to Consider Apollo Offer
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Market Chatter: Paramount Global Asked by Activist Investor to Consider Apollo Offer
Apr 12, 2024 11:17 AM

02:06 PM EDT, 04/12/2024 (MT Newswires) -- (Updates with additional details in the second, third, and fourth paragraphs.)

Paramount Global ( PARAA ) was asked by activist investor Barington Capital Group to end exclusive talks with David Ellison and consider rival offers, including one from Apollo Global Management ( APO ) , Bloomberg News reported Friday, citing a letter to the company's board it reviewed.

Ellison is looking to take over Paramount via a deal that would merge his company, Skydance Media, with the entertainment conglomerate, and is willing to pay more than $2 billion for National Amusements, which owns a majority of Paramount's voting stock, the report said.

Barington Capital Group, which has a small stake in the conglomerate, has objected to certain reported terms of the deal, Bloomberg said.

"By choosing not to negotiate with other parties or permit them to conduct due diligence, the special committee has effectively chilled the process" of competitive bidding, Barington Capital Group Chief Executive James Mitarotonda said in the letter, according to the report.

Apollo Global Management ( APO ) declined to comment and Paramount Global ( PARAA ) and Barington Capital Group did not immediately reply to MT Newswires' requests for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 11.07, Change: -0.20, Percent Change: -1.77

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Redfin Selects Magnite as Preferred Sell-Side Platform
Redfin Selects Magnite as Preferred Sell-Side Platform
May 26, 2025
09:47 AM EDT, 05/14/2025 (MT Newswires) -- Redfin (RDFN) has chosen Magnite ( MGNI ) as its preferred sell-side platform to connect advertisers with homebuyers, the companies said Wednesday. Under the companies' partnership, Redfin will leverage Magnite's ( MGNI ) programmatic technology to provide brands with national scale and hyper-local targeting, the companies said. Financial terms of the collaboration were...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Sabre, Avelo Airlines Sign Deal for SabreMosaic Ancillary IQ Platform
Sabre, Avelo Airlines Sign Deal for SabreMosaic Ancillary IQ Platform
May 26, 2025
09:48 AM EDT, 05/14/2025 (MT Newswires) -- Sabre (SABR) and Avelo Airlines said Wednesday they have signed a new deal for Avelo to adopt Sabre's artificial intelligence-powered SabreMosaic Ancillary IQ platform for ancillary service optimization. Financial terms were not disclosed. The parties also renewed their collaboration for the airline to adopt Sabre's Radixx platform for its retailing and operational requirements,...
ATyr Pharma Plans Investigational New Drug Filing for ATYR0101 in Pulmonary Fibrosis
ATyr Pharma Plans Investigational New Drug Filing for ATYR0101 in Pulmonary Fibrosis
May 26, 2025
09:47 AM EDT, 05/14/2025 (MT Newswires) -- ATyr Pharma ( ATYR ) said Wednesday it has advanced ATYR0101 to the investigational new drug candidate stage to potentially treat pulmonary fibrosis. Chief Executive Sanjay S. Shukla said they anticipate filing an IND application in H2 of 2026. The company said preclinical data showed ATYR0101 can induce cell death of myofibroblasts through...
Copyright 2023-2026 - www.financetom.com All Rights Reserved